Eterna Therapeutics
ERNA
#9228
Rank
NZ$93.56 M
Marketcap
$1.82
Share price
-5.26%
Change (1 day)
-6.62%
Change (1 year)

P/S ratio for Eterna Therapeutics (ERNA)

P/S ratio as of November 2024 (TTM): 342

According to Eterna Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -6.51. At the end of 2024 the company had a P/S ratio of 61.1.

P/S ratio history for Eterna Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202461.1-57.21%
2023143
2022N/A
2021N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.15-99.66%๐Ÿ‡บ๐Ÿ‡ธ USA
> 1000 410.50%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
2.40-99.30%๐Ÿ‡ซ๐Ÿ‡ท France
10.2-97.02%๐Ÿ‡บ๐Ÿ‡ธ USA
0.2181-99.94%๐Ÿ‡ฆ๐Ÿ‡บ Australia
1.20-99.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel